Outlook Therapeutics Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Outlook Therapeutics Inc. stock price ended at $8.92 on Tuesday, after losing 1.98%.
(Updated on Apr 30, 2024)
The Outlook Therapeutics Inc. stock price fell by -1.98% on the last day (Tuesday, 30th Apr 2024) from $9.10 to $8.92. During the last trading day the stock fluctuated 5.09% from a day low at $8.84 to a day high of $9.29. The price has fallen in 6 of the last 10 days but is still up by 1.94% over the past 2 weeks. Volume has increased on the last day by 57 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 203 thousand shares were bought and sold for approximately $1.82 million.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 307.15% during the next 3 months and, with a 90% probability hold a price between $27.97 and $66.38 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
OTLK Signals & Forecast
There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Thursday, March 28, 2024, and so far it has fallen -25.29%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. The Outlook Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $8.45 and $8.16. A breakdown below any of these levels will issue sell signals.
Support, Risk & Stop-loss for Outlook Therapeutics Inc. stock
Outlook Therapeutics Inc. finds support from accumulated volume at $8.63 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.450 between high and low, or 5.09%. For the last week, the stock has had daily average volatility of 6.75%.
Our recommended stop-loss: $8.56 (-4.03%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 22 days ago.)
Trading Expectations (OTLK) For The Upcoming Trading Day Of Wednesday 1st
For the upcoming trading day on Wednesday, 1st we expect Outlook Therapeutics Inc. to open at $9.02, and during the day (based on 14 day Average True Range), to move between $8.12 and $9.72, which gives a possible trading interval of +/-$0.796 (+/-8.92%) up or down from last closing price. If Outlook Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 17.84% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $8.63 (3.25%) than the resistance at $9.37 (5.04%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Outlook Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Outlook Therapeutics Inc. stock to perform well in the short-term.
Current score: 2.503 Buy Candidate Unchanged
Predicted Opening Price for Outlook Therapeutics Inc. of Wednesday, May 1, 2024
Fair opening price May 1, 2024 | Current price |
---|---|
$9.02 ( 1.08%) | $8.92 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for OTLK
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 9.47 | 6.13 % | |
R2 | 9.29 | 4.20 % | ||
R1 | 9.19 | 3.01 % | ||
Current price: | 8.92 | |||
Support | S1 | 8.84 | -0.84 % | |
S2 | 8.74 | -2.03 % | ||
S3 | 8.57 | -3.96 % |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 10.26 | 15.02 % | |
R2 | 9.70 | 8.74 % | ||
R1 | 9.37 | 5.04 % | ||
Current price | 8.92 | |||
Support | S1 | 8.63 | -3.25% | |
S2 | 8.51 | -4.60% | ||
S3 | 8.24 | -7.62% |
FAQ
Click here for our free guide on how to buy Outlook Therapeutics Inc. Stock.